Skip to content

The Beauty Health Company SKIN Fair Value Adjustment Of Warrants

Fair Value Adjustment Of Warrants at other companies

SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
$0-100%

Other financials

Income statement

See full
Revenue$64.9M-6.7%
Gross profit$44.4M-8.5%
Operating income-$1.8M+85.0%
Net income-$6.6M+34.3%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$204.4M-45.2%
Total debt$125.9M+756%
Total equity$55.2M+19.9%
Total assets$473.2M-29.8%

Cash flow

See full
Operating cash flow-$5.6M-285%
CapEx$224.0K+398%
Free cash flow-$5.8M-296%

Valuation

See full
Market cap$89.75M-61.5%
Enterprise value$11.24M-96.2%
P/S0.3×-0.4×

Profitability

See full
Gross margin64.9%+8.3pp
Operating margin-3.6%-1.6pp
Net margin-2%-0.9pp
FCF margin9.6%

Returns & leverage

See full
Return on equity-12%-5.4pp
Debt / equity2.3×+2.0×
Current ratio1.8×-5.7×

Where this comes from

Reported directly by The Beauty Health Company in its filing.

Tagged under the XBRL concept us-gaap:FairValueAdjustmentOfWarrants.

The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beauty Health Company's fair value adjustment of warrants.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Beauty Health Company's fair value adjustment of warrants?
The Beauty Health Company (SKIN) reported fair value adjustment of warrants of $0 in Q1 2026.
How has The Beauty Health Company's fair value adjustment of warrants changed year-over-year?
The Beauty Health Company's fair value adjustment of warrants increased by 100.0% year-over-year, from -$349K to $0.
What is the long-term trend for The Beauty Health Company's fair value adjustment of warrants?
Over 4 years (2021 to 2025), The Beauty Health Company's fair value adjustment of warrants has grown at a -79.5% compound annual growth rate (CAGR), from $277.32M to -$487K.
What does fair value adjustment of warrants mean?
This reflects the non-cash gain or loss resulting from the periodic revaluation of outstanding warrant liabilities based on current market conditions and stock price volatility. Because these adjustments are driven by market fluctuations rather than core business operations, they are excluded from operating cash flow analysis. It provides insight into the potential dilution and financial risk associated with derivative instruments.